Moon responds to 59 deaths after flu vaccine: go ahead and get more people to get it

South Korea has reported 59 cases of deaths after flu vaccination as of the 26th, and the government has yet to call for a halt despite public concern, according to South Korea’s Joongang Daily. South Korean President Moon Jae-in responded to the matter for the first time that day, saying he hoped the public would trust the conclusions of health authorities and experts, and called for the continued expansion of flu vaccination.

In a meeting hosted by Cheong Wa Dae on the same day, Moon said that through the autopsies and comprehensive judgments carried out on the deaths, it has been determined that there is no direct causal relationship between the deaths after the flu vaccination and the vaccination.

Moon said it is necessary to continue to expand influenza vaccination in order to prevent influenza, as well as the simultaneous infection and spread of influenza and neo-crown. “I hope that you will not be too upset and miss the timely vaccination, and accidentally contract the highly lethal influenza and incur greater danger.”

In addition, he called on the health ministry to continue its efforts to eliminate unnecessary panic among the public by compiling and announcing the death cases following influenza vaccination in Korea over the past years, as well as the relevant situation abroad, while conducting quick examinations and releasing the results in a timely manner.

Deaths on the rise, vaccinations plummet (news 1)

Since the death of a 17-year-old boy in Incheon on Oct. 16, two days after receiving a flu vaccine, there have been cases of flu vaccine deaths all over South Korea, most of them over 70 years old, who died as little as four hours after receiving the vaccine.

The influenza vaccine used in the free vaccination program in Korea is reportedly supplied by five pharmaceutical companies, namely local GC Pharmaceuticals, SK Biotechnology and Ichiyo Pharmaceuticals, as well as France’s Sanofi Group and Britain’s GlaxoSmithKline. Distributors include South Korea’s LG Chem and Pauling Pharmaceuticals, among others.

The South Korean vaccine incident has aroused international concern, and late on the 25th night, the Singaporean health department issued a statement saying that in view of the many deaths reported in South Korea after receiving the influenza vaccine, although no deaths have been reported in Singapore after vaccination, but as a precautionary measure, Singapore has suspended the use of two influenza vaccines used in South Korea, namely SKYCellflu Quadrivalent and VaxigripTetra.